THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 36 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $0 | – | 327 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 327 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 327 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 327 | -97.1% | 0.00% | – |
| Q1 2016 | $5,000 | -75.0% | 11,291 | -73.6% | 0.00% | – |
| Q4 2015 | $20,000 | -88.6% | 42,837 | 0.0% | 0.00% | – |
| Q3 2015 | $175,000 | +1.2% | 42,837 | 0.0% | 0.00% | – |
| Q2 2015 | $173,000 | +4.2% | 42,837 | +4.6% | 0.00% | – |
| Q1 2015 | $166,000 | +35.0% | 40,968 | +6.3% | 0.00% | – |
| Q4 2014 | $123,000 | -3.9% | 38,540 | +9.0% | 0.00% | – |
| Q3 2014 | $128,000 | -12.3% | 35,363 | -4.3% | 0.00% | – |
| Q2 2014 | $146,000 | -20.7% | 36,952 | -4.3% | 0.00% | – |
| Q1 2014 | $184,000 | -0.5% | 38,627 | -2.7% | 0.00% | – |
| Q4 2013 | $185,000 | +0.5% | 39,711 | -0.2% | 0.00% | – |
| Q3 2013 | $184,000 | -19.3% | 39,776 | -8.1% | 0.00% | – |
| Q2 2013 | $228,000 | – | 43,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 270,500 | $1,288,000 | 1.11% |
| Rhenman & Partners Asset Management AB | 196,537 | $936,000 | 0.28% |
| FORTALEZA ASSET MANAGEMENT INC/ | 78,055 | $372,000 | 0.19% |
| Baker Brothers Advisors | 1,826,358 | $8,693,000 | 0.11% |
| Rotella Capital Management, Inc. | 14,600 | $69,000 | 0.08% |
| FRANKLIN STREET ADVISORS INC /NC | 69,700 | $332,000 | 0.07% |
| FEDERATED HERMES, INC. | 3,036,963 | $14,456,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 160,000 | $760,000 | 0.04% |
| SMITH ASSET MANAGEMENT GROUP LP | 200,118 | $953,000 | 0.04% |
| Princeton Alpha Management LP | 22,329 | $106,000 | 0.03% |